The Current State of Antifungal Stewardship in Immunocompromised Populations

被引：8

作者：

Alegria, William ^{[1
,2
]}

Patel, Payal K. ^{[3
,4
]}

机构：

[1] Stanford Hlth Care, Dept Qual Patient Safety & Effectiveness, 300 Pasteur Dr,Lane 134 L1C36, Stanford, CA 94305 USA

[2] Stanford Antimicrobial Safety & Sustainabil Progr, Stanford, CA 94305 USA

[3] Ann Arbor VA Med Ctr, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48105 USA

[4] Univ Michigan, Div Infect Dis, Dept Internal Med, 2215 Fuller Rd, Ann Arbor, MI 48105 USA

来源：

JOURNAL OF FUNGI | 2021年 / 7卷 / 05期

关键词：

antifungal stewardship; immunocompromised; invasive fungal infections; STAPHYLOCOCCUS-AUREUS BACTEREMIA; INVASIVE FUNGAL-INFECTIONS; QUALITY-OF-CARE; ACUTE-LEUKEMIA; RISK PATIENTS; DIAGNOSIS; IMPACT; POSACONAZOLE; MANAGEMENT; DISEASES;

D O I：

10.3390/jof7050352

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Inappropriate antifungal use is prevalent and can lead to drug-resistant fungi, expose patients to adverse drug events, and increase healthcare costs. While antimicrobial stewardship programs have traditionally focused on antibiotic use, the need for targeted antifungal stewardship (AFS) intervention has garnered interest in recent years. Despite this, data on AFS in immunocompromised patient populations is limited. This paper will review the current state of AFS in this complex population and explore opportunities for multidisciplinary collaboration.

引用

页数：11

共 66 条

[61] Antifungal stewardship in a tertiary-care institution: a bedside intervention [J].

Valerio, M. ;

Munoz, P. ;

Rodriguez, C. G. ;

Caliz, B. ;

Padilla, B. ;

Fernandez-Cruz, A. ;

Sanchez-Somolinos, M. ;

Gijon, P. ;

Peral, J. ;

Gayoso, J. ;

Frias, I. ;

Salcedo, M. ;

Sanjurjo, M. ;

Bouza, E. ;

Bustinza, A. ;

Escribano, P. ;

Fernandez-Cruz, A. ;

Fernandez-Quero, J. ;

Frias, I. ;

Gayoso, J. ;

Guinea, J. ;

Kestler, M. ;

de Lorenzo, A. ;

Martinez, M. C. ;

Menarguez, M. C. ;

Munoz, P. ;

Navarro, M. ;

Padilla, B. ;

Pelaez, T. ;

Rincon, D. ;

Sanchez, C. ;

Sanchez-Somolinos, M. ;

Sanjurjo, M. ;

Serrano, D. ;

Valerio, M. ;

Vena, A. ;

Verde, E. ;

Zamora, E. .

CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (05) :492.e1-492.e9

[62] How much European prescribing physicians know about invasive fungal infections management? [J].

Valerio, Maricela ;

Vena, Antonio ;

Bouza, Emilio ;

Reiter, Nanna ;

Viale, Pierluigi ;

Hochreiter, Marcel ;

Giannella, Maddalena ;

Munoz, Patricia .

BMC INFECTIOUS DISEASES, 2015, 15

[63] Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed [J].

Valerio, Maricela ;

Guadalupe Rodriguez-Gonzalez, Carmen ;

Munoz, Patricia ;

Caliz, Betsabe ;

Sanjurjo, Maria ;

Bouza, Emilio .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) :1993-1999

[64] Efficacy of a "Checklist" Intervention Bundle on the Clinical Outcome of Patients with Candida Bloodstream Infections: A Quasi-Experimental Pre-Post Study [J].

Vena, Antonio ;

Bouza, Emilio ;

Corisco, Rafael ;

Machado, Marina ;

Valerio, Maricela ;

Sanchez, Carlos ;

Munoz, Patricia .

INFECTIOUS DISEASES AND THERAPY, 2020, 9 (01) :119-135

[65] Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia [J].

Weis, Taylor M. ;

Marini, Bernard L. ;

Bixby, Dale L. ;

Perissinotti, Anthony J. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 141 :125-138

[66] An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia [J].

White, P. Lewis ;

Price, Jessica S. ;

Posso, Raquel B. ;

Barnes, Rosemary A. .

MEDICAL MYCOLOGY, 2017, 55 (08) :843-850

← 1 2 3 4 5 6 7 →